vs

Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $76.4M, roughly 1.4× PROCEPT BioRobotics Corp). American Assets Trust, Inc. runs the higher net margin — 6.1% vs -39.1%, a 45.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs 1.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs -0.1%).

Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AAT vs PRCT — Head-to-Head

Bigger by revenue
AAT
AAT
1.4× larger
AAT
$110.6M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+10.1% gap
PRCT
11.9%
1.8%
AAT
Higher net margin
AAT
AAT
45.2% more per $
AAT
6.1%
-39.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
-0.1%
AAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AAT
AAT
PRCT
PRCT
Revenue
$110.6M
$76.4M
Net Profit
$6.7M
$-29.8M
Gross Margin
60.6%
Operating Margin
23.4%
-40.6%
Net Margin
6.1%
-39.1%
Revenue YoY
1.8%
11.9%
Net Profit YoY
-16.3%
-58.3%
EPS (diluted)
$0.08
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAT
AAT
PRCT
PRCT
Q1 26
$110.6M
Q4 25
$110.1M
$76.4M
Q3 25
$109.6M
$83.3M
Q2 25
$107.9M
$79.2M
Q1 25
$108.6M
$69.2M
Q4 24
$113.5M
$68.2M
Q3 24
$122.8M
$58.4M
Q2 24
$110.9M
$53.4M
Net Profit
AAT
AAT
PRCT
PRCT
Q1 26
$6.7M
Q4 25
$-29.8M
Q3 25
$4.5M
$-21.4M
Q2 25
$5.5M
$-19.6M
Q1 25
$42.5M
$-24.7M
Q4 24
$-18.9M
Q3 24
$16.7M
$-21.0M
Q2 24
$11.9M
$-25.6M
Gross Margin
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
59.4%
60.6%
Q3 25
60.5%
64.8%
Q2 25
62.6%
65.4%
Q1 25
62.0%
63.9%
Q4 24
61.3%
64.0%
Q3 24
65.5%
63.2%
Q2 24
63.6%
59.0%
Operating Margin
AAT
AAT
PRCT
PRCT
Q1 26
23.4%
Q4 25
21.1%
-40.6%
Q3 25
22.6%
-27.8%
Q2 25
24.1%
-28.0%
Q1 25
66.3%
-39.7%
Q4 24
26.5%
-28.9%
Q3 24
30.8%
-38.4%
Q2 24
27.8%
-50.3%
Net Margin
AAT
AAT
PRCT
PRCT
Q1 26
6.1%
Q4 25
-39.1%
Q3 25
4.1%
-25.7%
Q2 25
5.1%
-24.7%
Q1 25
39.2%
-35.8%
Q4 24
-27.6%
Q3 24
13.6%
-35.9%
Q2 24
10.7%
-48.0%
EPS (diluted)
AAT
AAT
PRCT
PRCT
Q1 26
$0.08
Q4 25
$0.06
$-0.54
Q3 25
$0.07
$-0.38
Q2 25
$0.09
$-0.35
Q1 25
$0.70
$-0.45
Q4 24
$0.14
$-0.34
Q3 24
$0.28
$-0.40
Q2 24
$0.20
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAT
AAT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$118.3M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$1.1B
$365.9M
Total Assets
$2.9B
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAT
AAT
PRCT
PRCT
Q1 26
$118.3M
Q4 25
$129.4M
$286.5M
Q3 25
$138.7M
$294.3M
Q2 25
$143.7M
$302.7M
Q1 25
$143.9M
$316.2M
Q4 24
$425.7M
$333.7M
Q3 24
$533.0M
$196.8M
Q2 24
$114.9M
$214.1M
Total Debt
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
$1.7B
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$2.0B
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
AAT
AAT
PRCT
PRCT
Q1 26
$1.1B
Q4 25
$1.2B
$365.9M
Q3 25
$1.2B
$380.3M
Q2 25
$1.2B
$385.8M
Q1 25
$1.2B
$389.2M
Q4 24
$1.2B
$402.2M
Q3 24
$1.2B
$241.2M
Q2 24
$1.2B
$251.8M
Total Assets
AAT
AAT
PRCT
PRCT
Q1 26
$2.9B
Q4 25
$2.9B
$508.1M
Q3 25
$2.9B
$511.5M
Q2 25
$3.0B
$513.1M
Q1 25
$3.0B
$519.4M
Q4 24
$3.3B
$534.0M
Q3 24
$3.4B
$374.1M
Q2 24
$3.0B
$374.4M
Debt / Equity
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
1.48×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
1.72×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAT
AAT
PRCT
PRCT
Operating Cash FlowLast quarter
$-10.3M
Free Cash FlowOCF − Capex
$-12.2M
FCF MarginFCF / Revenue
-15.9%
Capex IntensityCapex / Revenue
14.5%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
$167.1M
$-10.3M
Q3 25
$40.5M
$-6.6M
Q2 25
$49.2M
$-15.0M
Q1 25
$36.9M
$-17.0M
Q4 24
$207.1M
$-32.4M
Q3 24
$52.4M
$-18.8M
Q2 24
$59.3M
$-15.7M
Free Cash Flow
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
$94.9M
$-12.2M
Q3 25
$23.1M
$-9.5M
Q2 25
$28.4M
$-17.8M
Q1 25
$20.4M
$-18.8M
Q4 24
$136.9M
$-33.6M
Q3 24
$28.0M
$-19.0M
Q2 24
$43.6M
$-16.8M
FCF Margin
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
86.2%
-15.9%
Q3 25
21.1%
-11.4%
Q2 25
26.3%
-22.5%
Q1 25
18.8%
-27.2%
Q4 24
120.7%
-49.2%
Q3 24
22.8%
-32.6%
Q2 24
39.3%
-31.4%
Capex Intensity
AAT
AAT
PRCT
PRCT
Q1 26
14.5%
Q4 25
65.6%
2.4%
Q3 25
15.9%
3.4%
Q2 25
19.3%
3.5%
Q1 25
15.1%
2.7%
Q4 24
61.9%
1.7%
Q3 24
19.9%
0.4%
Q2 24
14.1%
2.0%
Cash Conversion
AAT
AAT
PRCT
PRCT
Q1 26
Q4 25
Q3 25
8.98×
Q2 25
9.01×
Q1 25
0.87×
Q4 24
Q3 24
3.15×
Q2 24
4.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAT
AAT

Rental income$104.4M94%
Other$6.2M6%

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons